Regenerative medicines hold the ability treplace, repair, and regenerate tissues and organs that are affected due tsome disease, injury, or natural ageing process. These medicines are capable of restoring the functionality of tissues & cells applicable in a wide range of degenerative disorders such as neurodegenerative diseases, dermatology, cardiovascular and orthopedic applications. Researchers have been focusing on the development of advanced technologies based on genes, biologics, somatic cells and stem cells. Stem cells have the capability tproliferate and differentiate owing twhich they are of importance in this field. Currently, predominant treatments available for degenerative or life-threatening diseases dnot provide a treatment or are palliative; however, regenerative medicines have the ability treplace or regenerate the tissues and organs suffering from injury or disease. Moreover, the exploitation of nano-materials in drug delivery, wound care and immunomodulation are opportunistic for the regenerative medicine market.
Based on material, the market is classified intsynthetic materials, biologically derived materials, genetically engineered materials, and pharmaceuticals. The world regenerative medicine market is expected treach $30,237 million by 2022 at a CAGR of 33.1% during 2016-2022. These materials are further subcategorized intdifferent segments. The biologically derived materials accounted for about 4/7th of total market share in 2015, and is estimated tretain its position during the analysis period. The increasing demand for genetically engineered materials specially due ttheir unique properties such as promotion of increased proliferation, cellular interactions, and differentiation of cells that facilitates self-assembly intorganized structures, and controlling the manipulation of cellular behavior.
Get Free Sample Report of Regenerative Medicine Market @ http://www.intenseresearch.com/market-analysis/regenerative-medicine-market-by-technology-cell-therapy-gene.html#request-sample
The growth of this market is attributed by the factors such as an emergence of stem cell technology, valuable potential of nanotechnology, rising prevalence of chronic diseases & trauma emergencies, innovation in monitoring devices and surgical technologies. Moreover, rising incidence of degenerative diseases specifically and shortage for organ transplants has boosted the market growth. Furthermore, the increasing focus on stem cells with new source, and getting core competency in the emerging economies are expected tsupplement the growth in future. The developing nations are adopting technological advanced treatment modalities at a rapid pace, which is expected tassist in the market expansion worldwide. However, operational inefficiency, stringent regulations, and the high cost of the treatment through regenerative medicine deters the market progression.
The report segments the world regenerative medicine market based on product type, material, application, and geography. Based on product type, it is categorized intcell therapy, gene therapy, tissue engineering, and small molecules & biologics. Cell therapy dominated the market among all other products owing tits efficiency trestore the lost function of any tissue or organ. However, the small molecules & biologics segment is anticipated tgrow at a highest CAGR of 34.2% from 2016 t2022, due tits potential tstimulate dormant or endogenous cells tregain their regenerative properties.
- The report includes an extensive analysis of the factors driving as well as restraining the world regenerative medicine market.
- The study provides an in-depth analysis of the market with current trends and future estimations telucidate the imminent investment pockets.
- The report provides a quantitative analysis from 2014 t2022 that is expected tenable the stakeholders tcapitalize on prevailing market opportunities.
- Extensive analysis by product, material, application, and geography helps in understanding the various types of devices used for different chronic abnormalities.
- Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.
Key Market Segments:
- Cell Therapy
- Gene Therapy
- Tissue Engineering
- Small Molecules & Biologics
- Synthetic Materials
- Biodegradable Synthetic Polymers
- Artificial Vascular Graft Materials
- Hydrogel Material
- Biologically Derived Materials
- Xenogeneic Material
- Genetically Engineered Materials
- Deoxyribonucleic Acid Transfection Vectors
- Genetically Manipulated Cells
- Three-Dimensional Polymer Technology
- Neural Stem Cells
- Gene-Activated Matrices
- Small Molecules
- Wound Healing
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- Republic of South Africa
- Rest of LAME
About Intense Research
Intense Research provides a range of marketing and business research solutions designed for our client’s specific needs based on our expert resources. The business scopes of Intense Research cover more than 30 industries includsing energy, new materials, transportation, daily consumer goods, chemicals, etc. We provide our clients with one-stop solution for all the research requirements.
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442,
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 1-855-465-4651